发明申请
- 专利标题： Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors
- 专利标题（中）： 环丙基稠合吲哚扎嗪氮芥HCV NS5B抑制剂
-
申请号： US11745090申请日： 2007-05-07
-
公开(公告)号： US20070270406A1公开(公告)日： 2007-11-22
- 发明人: Robert G. Gentles , Piyasena Hewawasam , Min Ding , Carl P. Bergstrom , Scott W. Martin , Kap-Sun Yeung , Thomas W. Hudyma , Xiaofan Zheng , John A. Bender , John F. Kadow
- 申请人： Robert G. Gentles , Piyasena Hewawasam , Min Ding , Carl P. Bergstrom , Scott W. Martin , Kap-Sun Yeung , Thomas W. Hudyma , Xiaofan Zheng , John A. Bender , John F. Kadow
- 专利权人： Bristol-Myers Squibb Company
- 当前专利权人： Bristol-Myers Squibb Company
- 主分类号： A61K31/55
- IPC分类号： A61K31/55 ; C07D487/04
摘要：
The invention encompasses compounds of formula I as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV.
公开/授权文献
- US07521441B2 Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors 公开/授权日：2009-04-21
信息查询
